Keynote 716 Pembrolizumab For Patients With High Risk Stage Ii Melanoma

Ines Pires da Silva, MD, PhD,

Omid Hamid, MD, The Angeles Clinic and Research Institute, Los Angeles, CA, discusses the design and the findings from the ...

Jason Luke reports on key results from ESMO Congress 2021 on LBA3 -

Thomas Eigentler, MD, University of Tübingen, Tübingen, Germany, comments on the results of a key clinical trial presented

...

Jason J. Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, summarises the

Dr Luke talks to ecancer

This study looked at the use of

Jason J. Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, discusses the results of the

Summary In this episode of

Jason Luke, MD, FACP, UPMC Hillman Cancer Center, Pittsburgh, PA, comments on updated results from the

Summary In this episode of

Jason Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, comments on the distant metastasis-free survival (DMFS) analysis ...

Jason J. Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, discusses adjuvant therapy for

Reporting from ASCO 2022 Annual Meeting in Chicago, Georgina Long features the metastasis-free survival data from ...

... efficacy of adjuvant therapy with

AIM

Dr Georgina Long speaks to ecancer about

Dr Sapna Patel speaks to ecancer about the SWOG S1801 trial which studied the use of neoadjvuant versus adjuvant ...

Prof Eggermont presents results